These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
101 related articles for article (PubMed ID: 6889397)
1. Orphan drugs and orphan diseases: clinical realities and public policy. Proceedings of a conference, Ann Arbor, Michigan, September 27-29, 1982. Prog Clin Biol Res; 1983; 127():1-263. PubMed ID: 6889397 [No Abstract] [Full Text] [Related]
2. Studies involving orphan products for treating/diagnosing women's diseases. Haffner ME Food Drug Law J; 1993; 48(2):205-11. PubMed ID: 11653144 [No Abstract] [Full Text] [Related]
3. Should the patent system for new medicines be abolished? DiMasi JA; Grabowski HG Clin Pharmacol Ther; 2007 Nov; 82(5):488-90. PubMed ID: 17952100 [No Abstract] [Full Text] [Related]
4. Medication use in an imperfect world: drug misadventuring as an issue of public policy, Part 2. Manasse HR Am J Hosp Pharm; 1989 Jun; 46(6):1141-52. PubMed ID: 2750765 [No Abstract] [Full Text] [Related]
5. Economic and policy implications of reimportation: a Canadian perspective. Ward C Manag Care; 2004 Mar; 13(3 Suppl):17-20. PubMed ID: 15074165 [No Abstract] [Full Text] [Related]
6. AIDS treatment drugs: clinical trials and compassionate use. Levine RJ AIDS Public Policy J; 1987; 2(2):6-8. PubMed ID: 11650031 [No Abstract] [Full Text] [Related]
7. Cost of HIV drugs. American Public Health Association Am J Public Health; 1991 Feb; 81(2):250. PubMed ID: 11642863 [No Abstract] [Full Text] [Related]
8. Adopting orphan drugs: Congress tries to encourage new remedies for rare diseases. Wallis C Time; 1982 Oct; 120(15):76, 79. PubMed ID: 10317248 [No Abstract] [Full Text] [Related]
9. Cooperative approaches to research and development of orphan drugs. Proceedings of a conference. New York, New York, April 9 and 10, 1984. Prog Clin Biol Res; 1985; 197():1-204. PubMed ID: 4070283 [No Abstract] [Full Text] [Related]
13. When drugs are in short supply. Zurlinden J Nurs Spectr (Wash D C); 1999 Feb; 9(4):15-6. PubMed ID: 10542818 [No Abstract] [Full Text] [Related]
14. AIDS and drug pricing: in search of a policy. Salbu SR Wash Univ Law Q; 1993; 71(3):691-734. PubMed ID: 11652750 [No Abstract] [Full Text] [Related]
15. "Orphan drugs" for the Third World. Simon HJ Ann Intern Med; 1981 Aug; 95(2):231-2. PubMed ID: 7258877 [No Abstract] [Full Text] [Related]
16. The cost of AZT. Thomas EH; Fox DM AIDS Public Policy J; 1987; 2(2):17-21. PubMed ID: 11650027 [No Abstract] [Full Text] [Related]
17. Orphan drug development in the United States. Groft SC CPJ; 1985 May; 118(5):219-22. PubMed ID: 10271306 [TBL] [Abstract][Full Text] [Related]
18. This pill will change everything about abortion. Talbot M N Y Times Mag; 1999 Jul; ():38-43, 48, 61-6. PubMed ID: 11647700 [No Abstract] [Full Text] [Related]
19. The fuel to run the orphan drug engine: a medical school-based Orphan Disease Center Program. Brewer GJ Prog Clin Biol Res; 1985; 197():123-38. PubMed ID: 4070287 [No Abstract] [Full Text] [Related]
20. TRIPS, pharmaceutical patents, and access to essential medicines: a long way from Seattle to Doha. 't Hoen E Chic J Int Law; 2002; 3(1):27-46. PubMed ID: 15709298 [No Abstract] [Full Text] [Related] [Next] [New Search]